36th Annual Meeting and Exposition
of the Controlled Release Society
July 18-22, 2009
Bella Center
Copenhagen, Denmark
Bioactive Materials and Veterinary Mini-Symposia Speakers and Topics
AIDS – Back to Basics
Mario Clerici, Milano University, Italy, New Concepts in the Immunopathogenesis of HIV
Patrick Kiser, University of Utah, U.S.A., Delivery Systems Designed to Prevent HIV Transmission
Virendra Pandey, University of Medicine and Dentistry of New Jersey, U.S.A., Targeting Critical Regions of HIV-1 Genome for Intervention of HIV-1 Replication
Patrick Sinko, Rutgers University, U.S.A., Active Targeting OF HIV Sanctuary Sites Using Biodegradable Peptide-Based PEG Nanocarriers
Hydrogels - From Nanoparticulate Drug Carriers to Tissue Engineering Scaffold
Franco Alhaique, Università di Roma, Italy, Polysaccharide Beads
Rolando Barbucci, University of Siena, Italy, Biomedical Applications of Polysaccharide Hydrogels
Bice Conti, University of Pavia, Italy, Hydrogels Nanocarriers for Protein Delivery
Emo Chiellini, University of Pisa, Italy, Nanosized Hydrogels Constructs in Controlled Release of Bioactive Agents
Wim E. Hennink, University of Utrecht, The Netherlands, In Situ Forming Hydrogels for Protein Delivery
Giovanna Pitarresi, University of Palermo, Italy, Hybrid Systems for Tissue Engineering
Elisabetta Ranucci, University of Milano, Italy, Polyamidoamine Hydrogels for Cell Cultures and Tissue Engineering
Sheila MacNeil, University of Sheffield, United Kingdom, Development of Biopolymers for Tissue Engineering and Wound Healing Purposes
William L. Murphy, University of Wisconsin, U.S.A., Dynamic Protein Based Materials for Controlled Release
Innovations in Drug Delivery for Animal and Human Health Applications
Elias Fattal, University of Paris-XI, France, Delivery Systems for the Removal of Colonic Residual Antibiotic to Reduce the Emergence of Resistances
Mathieu Peyrou, Novartis Animal Health, Switzerland, Innovative PK Approaches in the Development of Controlled Release Veterinary Drugs
Michael Roberts, University of Queensland, Australia, Enhancement Strategies in Skin Penetration of Solutes and Nanoparticles: Species Differences
Thierry Vandamme, University of Strasbourg, France, Drug Delivery Systems Developed for Animal Health Applications
Malaria, 1 Million Deaths a Year and Still Counting!
Anne Grobler, North-West University, South Africa
Song Jian-Ping, Guangzhou University of Chinese Medicine, China
Solomon Nwaka, World Health Organization, Switzerland
Richard Haynes, Hong Kong University of Science and Technology, China, Artemisins-Marvellous Antimalrian Drugs-Advantages and Shortcomings
Neurodegeneration – Stopping the Clock
Christian Czech, F. Hoffmann-LaRoche, Switzerland, Disease Modification and New Biomarkers for Alzheimer’s Disease
Paul Gellert, AstraZeneca, U.K., Linking Disease and Delivery
John Hardy, National Institutes of Health, U.S.A., Fundamental Biology: New Therapeutic Opportunities
Samuel Svensson, AstraZeneca, Sweden
Translational Medicine–From the Lab to the Patient
Ruth Duncan, Cardiff University, U.K.
Jeff Evans, University of Glasgow Cancer Research, Scotland, Anti-Cancer Drug Development: Promises and Pitfalls
Tim Higenbottam, Chiesi Farmaceutici SpA, Italy
Alberto Gabizon, Shaare Zedek MC, Israel, Liposome Applications in Cancer Therapy-Doing New Tricks to Old Drugs
All speakers, topics, and titles are subject to change.
|